NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Clinical trials for NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could this trial cut a second surgery for bladder cancer patients?
Disease control Recruiting nowThis study is testing if a new approach can safely help some bladder cancer patients avoid a second surgery. It compares a special imaging-guided surgery to the current standard, which involves two surgeries. The goal is to see if the new method controls the cancer just as well w…
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE4 • Sponsor: University of Roma La Sapienza • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New bladder cancer injection enters first human safety tests
Disease control Recruiting nowThis early-stage trial is testing a new drug called belzupacap sarotalocan (AU-011) for bladder cancer that hasn't spread into the muscle wall. Researchers will inject the drug directly into tumors during a standard bladder procedure to see if it's safe and practical to use. The …
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New drug combo aims to save bladders from cancer surgery
Disease control Recruiting nowThis study is testing a combination of two immunotherapy drugs, durvalumab and monalizumab, for people with early-stage bladder cancer that has not responded well to the standard BCG treatment. The goal is to see if this drug combination can eliminate the cancer and help patients…
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: John Sfakianos • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New Bladder-Sparing cancer fight: immune drug challenges chemo
Disease control Recruiting nowThis study is for people with a specific type of high-grade bladder cancer that has not spread into the muscle wall. It compares two different treatment combinations, both given with radiation therapy. One group gets a standard chemotherapy drug, while the other gets an immunothe…
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC
-
Blood and urine test could help surgeons spot hidden bladder cancer
Diagnosis Recruiting nowThis study is testing whether a new combination of tests can better identify invasive bladder cancer before a patient has surgery to remove their bladder. Researchers will check if a special blood test and urine test, used alongside a standard scope exam, can accurately predict w…
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Sponsor: Fox Chase Cancer Center • Aim: Diagnosis
Last updated Apr 01, 2026 14:41 UTC